Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 3016 AL 3030

Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020)

Rombouts F, Kusakabe KI, Hsiao CC, Gijsen HJM.

Expert Opin Ther Pat. 2021 Jan;31(1):25-52. doi: 10.1080/13543776.2021.1832463. Epub 2020 Dec 17.

From bedside to battlefield: intersection of ketone body mechanisms in geroscience with military resilience

Stubbs BJ, Koutnik AP, Volek JS, Newman JC.

Geroscience. 2021 Jun;43(3):1071-1081. doi: 10.1007/s11357-020-00277-y. Epub 2020 Oct 2.

Proceedings from the Fourth International Symposium on σ-2 Receptors: Role in Health and Disease

Izzo NJ, Colom-Cadena M, Riad AA, Xu J, Singh M, Abate C, Cahill MA, Spires-Jones TL, Bowen WD, Mach RH, Catalano SM.

eNeuro. 2020 Nov 4;7(6):ENEURO.0317-20.2020. doi: 10.1523/ENEURO.0317-20.2020. Print 2020 Nov/Dec.

Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease

Marucci G, Buccioni M, Ben DD, Lambertucci C, Volpini R, Amenta F.

Neuropharmacology. 2021 Jun 1;190:108352. doi: 10.1016/j.neuropharm.2020.108352. Epub 2020 Oct 6.

Effect of long-term omega-3 supplementation and a lifestyle multidomain intervention on intrinsic capacity among community-dwelling older adults: Secondary analysis of a randomized, placebo-controlled trial (MAPT study)

Giudici KV, de Souto Barreto P, Beard J, Cantet C, Araujo de Carvalho I, Rolland Y, Vellas B; MAPT DSA group.

Maturitas. 2020 Nov;141:39-45. doi: 10.1016/j.maturitas.2020.06.012. Epub 2020 Jun 26.

Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease

Ma WH, Chen AF, Xie XY, Huang YS.

Neuropharmacology. 2021 Jun 1;190:108342. doi: 10.1016/j.neuropharm.2020.108342. Epub 2020 Oct 9.

Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease

Wessels AM, Lines C, Stern RA, Kost J, Voss T, Mozley LH, Furtek C, Mukai Y, Aisen PS, Cummings JL, Tariot PN, Vellas B, Dupre N, Randolph C, Michelson D, Andersen SW, Shering C, Sims JR, Egan MF.

Alzheimers Dement. 2020 Nov;16(11):1483-1492. doi: 10.1002/alz.12164. Epub 2020 Oct 13.

Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease

Behl T, Kaur I, Fratila O, Brata R, Bungau S.

Int J Mol Sci. 2020 Oct 9;21(20):7443. doi: 10.3390/ijms21207443.

Relationship between Wine Consumption, Diet and Microbiome Modulation in Alzheimer's Disease

Moreno-Arribas MV, Bartolomé B, Peñalvo JL, Pérez-Matute P, Motilva MJ.

Nutrients. 2020 Oct 10;12(10):3082. doi: 10.3390/nu12103082.

The immune system on the TRAIL of Alzheimer's disease

Burgaletto C, Munafò A, Di Benedetto G, De Francisci C, Caraci F, Di Mauro R, Bucolo C, Bernardini R, Cantarella G.

J Neuroinflammation. 2020 Oct 13;17(1):298. doi: 10.1186/s12974-020-01968-1.

The involvement of NLRP3 inflammasome in the treatment of Alzheimer's disease

Feng YS, Tan ZX, Wu LY, Dong F, Zhang F.

Ageing Res Rev. 2020 Dec;64:101192. doi: 10.1016/j.arr.2020.101192. Epub 2020 Oct 13.

Scope of β-Secretase (BACE1)-Targeted Therapy in Alzheimer's Disease: Emphasizing the Flavonoid Based Natural Scaffold for BACE1 Inhibition

Das S, Sengupta S, Chakraborty S.

ACS Chem Neurosci. 2020 Nov 4;11(21):3510-3522. doi: 10.1021/acschemneuro.0c00579. Epub 2020 Oct 19.

The structure and phase of tau: from monomer to amyloid filament

Zeng Y, Yang J, Zhang B, Gao M, Su Z, Huang Y.

Cell Mol Life Sci. 2021 Mar;78(5):1873-1886. doi: 10.1007/s00018-020-03681-x. Epub 2020 Oct 19.

Copper Toxicity Links to Pathogenesis of Alzheimer's Disease and Therapeutics Approaches

Ejaz HW, Wang W, Lang M.

Int J Mol Sci. 2020 Oct 16;21(20):7660. doi: 10.3390/ijms21207660.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias